Navigation Links
QuantaLife, Inc. Receives Tax Credit for Development of Droplet Digital™ PCR
Date:12/6/2010

PLEASANTON, Calif., Dec. 6, 2010 /PRNewswire/ -- QuantaLife, Inc. has received a $244,000 Therapeutic Discovery Project Tax Credit from the Internal Revenue Service and the Department of Health and Human Services to support the development of Droplet Digital™ PCR.

Droplet Digital PCR makes it possible to count individual nucleic acid (RNA/DNA) molecules by partitioning samples into droplets, each of which can be amplified using PCR and digitized to provide absolute quantitative results. The platform was recently introduced at the American Society of Human Genetics and the Association for Molecular Pathology meetings. The QuantaLife Droplet Digital PCR system will be commercially available for research use in mid-2011.

QuantaLife will use the credit to continue the development and commercialization of Droplet Digital PCR.  Early studies with Droplet Digital PCR demonstrate several compelling advantages, including increased depth of detection of rare target molecules in highly homologous backgrounds and improved quantitative resolution between samples with similar DNA / RNA content.  QuantaLife Droplet Digital PCR achieves digital resolution without the expense of microfluidic chips. It requires minimal hands-on time and offers broad application flexibility.

The credit is in line with a 5-year, $6.2M grant that QuantaLife secured from the National Institutes of Health (NIH) in September 2010 to support the development of Droplet Digital PCR technology for detection of methicillin-resistant Staphylococcus aureus (MRSA) bacteria, a major cause of staph infection in hospital patients.

About the Patient Protection and Affordable Care Act of 2010

In March 2010 the federal government signed the Patient Protection and Affordable Care Act of

2010.  Part of the aim of this statute is to augment research supporting discovery of lifesaving therapies, reduce healthcare expenses, and improve competitiveness of domestic medical technology companies through the Qualifying Therapeutic Discovery Project Program. QuantaLife's tax credit was awarded as a grant under this program.

About QuantaLife, Inc.

QuantaLife has developed the 3rd generation of PCR technology that quantifies DNA molecules by Droplet Digital PCR. Droplet Digital PCR measures target nucleic acid molecules with unrivaled absolute quantitative resolution and sensitivity. Applications include copy number variation (CNV), mutation detection, and gene expression analysis. The company's mission is to provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.


'/>"/>
SOURCE QuantaLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. QuantaLife, a New Life Science Tool Company, Receives NIH Grant
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... VMS BioMarketing as senior vice president of sales, announced Andrea Heslin Smiley , ... the company,s business development and sales team, exploring new opportunities for VMS to empower ... ... ... ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
(Date:5/24/2016)... , May 24, 2016 ... elkaar verbindt, zodat zij collectief patiënten kunnen behandelen, hun ... is het idee achter de nieuwe en revolutionaire MDLinking ... van de Nederlandse vaatchirurg dr. Hans Flu en oncologisch ... app, die inmiddels beschikbaar is, wordt op dinsdag 24 ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... 2016 , ... Georgia State University College of Law is ... Answering to the increasing demand for curricular specializations, the Certificate in Intellectual Property ... land use law. ,  , “The demand for lawyers with specific knowledge in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is a ... on long-term patient survival, reports a team of UPMC researchers in the largest ... the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will hopefully ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, ... public. , Dr. Maisel, founder of Retina Group of New York , ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
(Date:5/26/2016)... San Rafael, CA (PRWEB) , ... May 26, ... ... Studio will be offering campers a multitude of activities from daily practices, arts ... and self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds ...
Breaking Medicine News(10 mins):